Literature DB >> 32270081

Endothelial function and lipid profile of individuals with schizophrenia participating in a supported employment program.

Jordana Lectzow de-Oliveira1, Ivy Reichert da-Silva1, Thiago Rozales Ramis1, Carmen Vera Ferreira1,2, Sandra Maria Soares1,2, Jerri Luiz Ribeiro1, Gilson Pires Dorneles3, Luciane Carniel Wagner1,4.   

Abstract

BACKGROUND: The social function of individuals with schizophrenia is usually poor and this population exhibits a sedentary lifestyle. Social participation, inclusion in the world of work in particular, might favorably interfere with the lives of these individuals by reducing sedentarism and improving their state of health.
OBJECTIVE: To analyze the lipid profile and endothelial function markers among individuals with schizophrenia enrolled in a supported employment program.
METHODS: Quantitative quasi-experimental study conducted with 14 individuals with schizophrenia enrolled in a labor inclusion program. Participants were assessed before enrolment (time-point 1) and one year later (time-point 2). Total cholesterol and fractions, triglycerides, serum nitrates and nitrites (endothelial function markers) were measured. The data were analyzed with software SPSS 20.
RESULTS: The high-density lipoprotein (HDL) and low-density lipoprotein (LDL) levels exhibited significant changes one year after inclusion in the labor market. HDL increased from 82.30 to 98.60 mg/dL (p<0.01) and LDL decreased from 54.50 to 44.45 mg/dL (p<0.02). The triglyceride and total cholesterol levels remained stable. The nitrate and nitrite level exhibited significant reduction from 15.20 to 14.48 µMol (p<0.01).
CONCLUSION: Participation in the supported employment program might have favorably influenced the participants' lipid profile and endothelial function. Nitrites have been described as mediators in the neural inflammatory process, and reduction of their levels is associated with better prognosis of chronic diseases such as schizophrenia.

Entities:  

Keywords:  cholesterol; endothelium; schizophrenia; work

Year:  2018        PMID: 32270081      PMCID: PMC7104833          DOI: 10.5327/Z1679443520180178

Source DB:  PubMed          Journal:  Rev Bras Med Trab        ISSN: 1679-4435


  16 in total

Review 1.  Nitric oxide, cardiovascular disease and physical exercise.

Authors:  Anderson Saranz Zago; Angelina Zanesco
Journal:  Arq Bras Cardiol       Date:  2006-12       Impact factor: 2.000

2.  [V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis].

Authors:  H T Xavier; M C Izar; J R Faria Neto; M H Assad; V Z Rocha; A C Sposito; F A Fonseca; J E dos Santos; R D Santos; M C Bertolami; A A Faludi; T L R Martinez; J Diament; A Guimarães; N A Forti; E Moriguchi; A C P Chagas; O R Coelho; J A F Ramires
Journal:  Arq Bras Cardiol       Date:  2013-10       Impact factor: 2.000

Review 3.  Nitrite and nitric oxide metabolism in peripheral artery disease.

Authors:  Jason D Allen; Tony Giordano; Christopher G Kevil
Journal:  Nitric Oxide       Date:  2012-03-14       Impact factor: 4.427

4.  Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine.

Authors:  Ronald R Brown; Michael W Estoup
Journal:  Int Clin Psychopharmacol       Date:  2005-03       Impact factor: 1.659

Review 5.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

7.  Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia?

Authors:  Medaim Yanik; Huseyin Vural; Abdurrahim Kocyigit; Hamdi Tutkun; Süleyman Salih Zoroglu; Hasan Herken; Haluk Asuman Savaş; Alpay Köylü; Omer Akyol
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

8.  Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia.

Authors:  Martha M. Kato; M Beatriz Currier; Christina M. Gomez; Lacresha Hall; Mercedes Gonzalez-Blanco
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

9.  Microvascular dysfunction in schizophrenia: a case-control study.

Authors:  Martin W Vetter; Billie-Jean Martin; Marinda Fung; Milada Pajevic; Todd J Anderson; Thomas J Raedler
Journal:  NPJ Schizophr       Date:  2015-07-01

10.  Influence of sociodemographic and clinical characteristics on the quality of life of patients with schizophrenia.

Authors:  Lara Guedes de Pinho; Anabela Pereira; Cláudia Chaves
Journal:  Rev Esc Enferm USP       Date:  2017-08-28       Impact factor: 1.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.